16.95
price up icon0.12%   0.02
after-market Dopo l'orario di chiusura: 16.95
loading

Urogen Pharma Ltd Borsa (URGN) Ultime notizie

pulisher
02:20 AM

How UroGen Pharma Ltd. stock compares to industry benchmarksJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - newser.com

02:20 AM
pulisher
10:28 AM

Can UroGen Pharma Ltd. stock sustain free cash flow growthJuly 2025 Fed Impact & Safe Entry Zone Tips - Trung tâm Dự báo KTTV quốc gia

10:28 AM
pulisher
10:03 AM

Is UroGen Pharma Ltd. stock bottoming outMarket Risk Report & Pattern Based Trade Signal System - newser.com

10:03 AM
pulisher
12:53 PM

Tick level data insight on UroGen Pharma Ltd. volatility2025 Market Sentiment & Expert Verified Movement Alerts - newser.com

12:53 PM
pulisher
Oct 16, 2025

Using AI based signals to follow UroGen Pharma Ltd.Market Sentiment Review & Comprehensive Market Scan Reports - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Is UroGen Pharma Ltd. (UR8) stock worth holding before Fed meetingJuly 2025 EndofMonth & Safe Entry Trade Reports - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Can UroGen Pharma Ltd. stock resist sector downturns2025 EndofYear Setup & Fast Entry High Yield Tips - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

UroGen Pharma Ltd Stock Analysis and ForecastFederal Reserve Announcements & Fast Growing Investment Ideas - earlytimes.in

Oct 14, 2025
pulisher
Oct 13, 2025

Why UroGen Pharma Ltd. (UR8) stock trades below fair valueTrade Risk Assessment & High Win Rate Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 11, 2025

Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Cuts Target Price to $36 - 富途牛牛

Oct 11, 2025
pulisher
Oct 11, 2025

Bender Robert & Associates Invests $475,000 in Urogen Pharma $URGN - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

What technical models suggest about UroGen Pharma Ltd.’s comebackJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com

Oct 11, 2025
pulisher
Oct 10, 2025

Chris Degnan Sells 2,203 Shares of Urogen Pharma (NASDAQ:URGN) Stock - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Understanding UroGen Pharma Ltd.’s price movementEarnings Beat & Safe Swing Trade Setups - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is UroGen Pharma Ltd. reversing from oversold territoryJuly 2025 Breakouts & Weekly High Return Opportunities - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is UroGen Pharma Ltd. (UR8) stock a momentum leaderJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Weiss Ratings Reiterates "Sell (D-)" Rating for Urogen Pharma (NASDAQ:URGN) - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

UroGen Pharma CFO Degnan sells $37k in shares By Investing.com - Investing.com South Africa

Oct 09, 2025
pulisher
Oct 09, 2025

UroGen Pharma CFO Degnan sells $37k in shares - Investing.com

Oct 09, 2025
pulisher
Oct 07, 2025

UroGen continues to climb after bladder cancer drug approval - MSN

Oct 07, 2025
pulisher
Oct 07, 2025

UroGen Pharma Ltd.'s (NASDAQ:URGN) Price Is Out Of Tune With Revenues - Sahm

Oct 07, 2025
pulisher
Oct 05, 2025

Is UroGen Pharma Ltd a good long term investmentVolatility Index Analysis & Consistent Triple Returns - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

UroGen Pharma Ltd. stock outlook for YEARPortfolio Value Report & Intraday High Probability Setup Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How to recover losses in UroGen Pharma Ltd. stock2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can swing trading help recover from UroGen Pharma Ltd. lossesJobs Report & High Accuracy Swing Entry Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com

Oct 03, 2025
pulisher
Oct 03, 2025

UroGen Pharma (URGN): Maintained Buy Rating by D. Boral Capital | URGN Stock News - GuruFocus

Oct 03, 2025
pulisher
Oct 03, 2025

Urogen Pharma (NASDAQ:URGN) Earns "Buy" Rating from D. Boral Capital - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Why UroGen Pharma Ltd. (UR8) stock stays on buy listsMarket Risk Analysis & Scalable Portfolio Growth Methods - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

UroGen’s bladder cancer treatment shows durable response in clinical trials By Investing.com - Investing.com Nigeria

Oct 03, 2025
pulisher
Oct 03, 2025

Can machine learning forecast UroGen Pharma Ltd. recoveryAnalyst Downgrade & Weekly Setup with ROI Potential - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

ZUSDURI™ Clinical Review Published in Reviews in Urology™ - GlobeNewswire

Oct 02, 2025
pulisher
Oct 02, 2025

Can IL FS Transportation Networks Limited Deliver Margin Expansion Amid InflationEquity Performance Review & Small Investment Portfolio Tips - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

What drives UroGen Pharma Ltd stock priceStock Market Trends & Smart Beta Strategies That Actually Work - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

URGN: UroGen Pharma's ZUSDURI Shows Promising Results for Bladder Cancer - GuruFocus

Oct 02, 2025
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):